Comparative genome hybridization (CGH) is a laboratory method to measure gains and losses of chromosomal regions in tumor cells. It is believed that DNA gains and losses in tumor cells do not occur entirely at random, but partly through some ow of causality. Models that relate tumor progression to the occurrence of DNA gains and losses could be very useful in hunting cancer genes and in cancer diagnosis. We lay some mathematical foundations for inferring a model of tumor progression from a CGH data set. We consider a class of tree models that are more general than a path model that has been developed for colorectal cancer. We derive a tree model inference algorithm based on the idea of a maximum-weight branching in a graph, and we show that under plausible assumptions our algorithm infers the correct tree. We have implemented our methods in software, and we illustrate with a CGH data set for renal cancer.
Introduction
Cancer is associated with a sequence of genetic changes that cause the cell cycle division, cell di erentiation, or cell death processes to go out of control. Tremendous advances in molecular biology have enabled researchers to measure genetic changes in tumor cells, but it is still very di cult to distinguish causes from e ects. Cancer genes can be broadly classi ed into two types: tumor suppressor genes and oncogenes. A tumor suppressor gene leads to cancer when there is a decrease of expression of the corresponding protein; an oncogene leads to cancer when there is an increase of expression of the corresponding protein. Our aim is to infer from the gains and losses of chromosomes and chromosome arms, which chromosomal regions are most likely to harbor important genes for tumor initiation, and which may be important for progression. We work with gain and loss information for regions of chromosomes, since this kind of a cytogenetic study provides a survey of the entire human genome at once. Furthermore, chromosomal alterations are known to lead to inactivation of tumor suppressor genes (by loss of chromosomal regions), or to oncogene activation (by gain of chromosomal regions).
Chromosomal abnormalities in cancer were rst discovered in a form of leukemia Now]. During the past 20 years many forms of leukemia and lymphoma have been found to be associated with speci c alterations. These studies have laid the foundations for contemporary cancer genetics. In solid forms of cancer, unlike leukemia and lymphoma, the study of chromosomal alterations has been di cult. An important problem in solid tumors is that once a set of critical genetic alterations develops, the cancer cell goes \out of control" and starts to accumulate seemingly random alterations. Since solid tumor samples often contain over a dozen chromosomal alterations it has proven di cult to identify the primary disease-causing events.
We focus on data collected by one important laboratory technique comparative genomic hybridization (CGH). CGH allows detection of all signi cant gains and losses in a single experiment per tumor Kal] . CGH has opened interesting possibilities for understanding oncogenesis, the process whereby cancers form. CGH is based on the fact that each chromosomal region of a healthy cell has two copies of its DNA in a cell. Deviations from this normal level are called copy number aberrations, or CNAs. Signi cant deviations, up or down, in a cancerous cell may signal that the region contains genes that play a role in the development of cancer.
The copy number of chromosomal regions can be measured in the laboratory by measuring uorescence on chromosomes where uorescently labeled tumor DNA and normal DNA have been allowed to bond together. Comparing with the corresponding numbers in a healthy cell, one can obtain a list of CNAs. This is done by calculating for each region the ratio of copy numbers between healthy and cancerous cells (by comparing uorescence of two colors), and selecting those regions for which this ratio is outside a range de ned by a lower and an upper threshold, r ? < 1 < r + , which take into account natural uctuations and experimental error.
An example of a successful application of CGH is the localization to chromosome 19 of a gene for Peutz-Jeghers syndrome Hem], a disease associated with pre-cancerous intestinal polyps. For a survey of CGH and its applications see For] .
Once we have the list of the copy number aberrations (CNAs) of a particular tumor, we can think of it as a set of genetic events that took place in some unknown order. It is believed that these events do not occur in a random fashion, but they are the result of some unknown ow of causality. That is, once an event occurs, it increases the probability of other events occurring, and so on. In some cases the connection between one event and the next will be speci c and directly causal, while in other cases the later event occurs seemingly at random because of the basic genetic instability in a tumor cell. A survey of many CGH studies shows some consistent patterns as to which CNAs occur most often in some types of tumors For] . By studying the sets of CNAs from many patients with the same kind of tumor, we may discover common patterns, ultimately we would like to infer the pathways whereby oncogenesis (the stochastic process in the genome which ultimately leads to cancer) proceeds. Models for tumor progression pathways would be of obvious value to the early diagnosis and treatment of cancer.
There has already been important work in this direction, notably the study of colorectal cancer by Vogelstein et al. Vog] . They inferred from a variety of types of data that the progression of colorectal cancer can be described by a chain of four genetic events, three of which are CNAs. When the rst of these events occurs, the chance of the second event occurring increases, and when the second event occurs the chances of the third increase, and so on. These events are irreversible, in that once an event occurs it is never undone in the future. The presence of all four events appears to be an indicator of colorectal cancer. While the path model suggests a most likely order of occurrence, colorectal cancer is really associated with the accumulation of the genetic changes on the path Vog].
The aim of the present paper is to build on the above-mentioned work on inferring the oncogenesis process from CNA data, and to develop its mathematical and computational foundations. Previous analyses of CGH data (see Kuu] and references therein) suggest that chain or path models similar to that in Vog] do not su ce to capture oncogenesis as suggested for colorectal cancer.
Therefore, we consider a more general tree-like model of oncogenesis. In other words, while Vog] restrict the causal sequence of genetic events causing cancer to straight-line chains such as that shown in Figure 1 (a), we allow a much more general family of models that branch like trees (Figure 1(b,c) ). By extending the set of models that we can handle, we increase our chances of correctly inferring how oncogenesis proceeds. Our models explicitly assume that the events may not be independent, in contrast to the work of Newton, Wu, and Rezniko New] who did a statistical analysis of a small set of chromosome loss data collected by cytogenetic methods. A correct model of oncogenesis would be valuable in suggesting narrow chromosome regions in which to focus subsequent experimental e ort, as well as the relative timing of such e orts.
In Section 2 of this paper we develop a mathematical theory of the oncogenesis process for tree-like models. The mathematical theory borrows from Markov processes and percolation theory. We distinguish between two styles of models, one akin to network reliability and the other involving time. We also de ne a statistic that may be valuable in distinguishing between events that occur early from those that occur late in oncogenesis.
In Section 3 we develop a methodology for inferring an oncogenesis tree from CNA data. Our methodology involves selecting a set of most relevant events, and then assigning to each pair of such events a weight related to the probabilities of joint or individual occurrence of these events. From these weights, we can recover the optimum oncogenesis tree as a maximum-weight branching corresponding to these weights. We prove that, under mild assumptions, our algorithm discovers the correct tree model of oncogenesis, if supplied with an appropriate amount of data.
Our analysis can be made quantitative to yield an estimation of the amount of data that would su ce for correct inference with high probability. Sample size estimation is important because data collection in oncology is costly.
In Section 4, we use our methodology to analyze CNA data for renal cancer from the laboratory of H. M. We use the e cient algorithm suggested by our method to nd a tree model that appears to capture the oncogenesis process for one category of renal cancer. We conclude in Section 5 with directions for future work.
Oncogenetic Trees
The result of a CGH test is a set of genetic events (in particular, a set of CNAs). A series of CGH tests results in a family of sets of CNAs, that is to say, a set of samples from a probabilistic distribution over all possible sets of genetic events. A model of oncogenesis should then be a random process which generates such sets of genetic events, and therefore de nes a distribution over sets of genetic events. In this section we propose several such models, most notably tree-based models.
Let us x a nite set V of possible genetic events. In practice, the genetic events are reported from the laboratory as a set of chromosome intervals gained or lost in each tumor. Human chromosomes are named/numbered 1 to 22 and X and Y (only in males). For our studies we have ignored Y because it is small and some of the data sets are female breast cancer samples.
All the chromosomes have a long arm, denoted q. All the chromosomes except 13, 14, 15, 21, 22 have signi cant genetic material on the short arm denoted p. Studies of chromosomes have long relied on the fact that di erent intervals, called bands, along the chromosome, are colored di erently after applying a stain. When two tumors have CNAs spanning approximately the same bands, we found it impossible to decide whether these re ect the same genetic change or not. Therefore, in our data analysis we used only the 41 chromosome arms and gain/loss to distinguish events. As a result, V contains 82 possible CNAs, plus a root note r. It is possible for the same chromosome arm to have both a gain and a loss (at di erent bands) in the same tumor. A (probability) distribution on 2 V is a function p assigning to each subset of V a nonnegative real number, and satisfying P S V p S] = 1. We shall consider graphs whose vertices are the genetic events in V , and which de ne distributions on 2 V . A rooted tree, or simply tree, on V is a triple T = (V; E; r), where r 2 V is a special vertex called the root, and E is a set of pairs of vertices such that (1) for each vertex v 2 V there is at most one edge (u; v) 2 E with v as its second component, (2) there is no edge (u; r) entering r, and (3) there is no cycle, that is, no sequence of edges in E of the form ((v 0 ; v 1 ); (v 1 ; v 2 ); : : : ; (v k?1 ; v k ); (v k ; v 0 )). For example, the graphs depicted in Figure 1 (a{d) are trees, while the graph in 1(e) is not. Notice that we allow trees to have disconnected components; for our analysis the interesting part of a tree will be the one reachable from r. There are two special kinds of trees, in some sense opposite extreme cases, that are of special interest in our application: A path is a tree with at most one edge leaving each vertex (Figure 1(a) ). A star is a tree in which all edges leave the root (Figure 1(b) ). Note that what we call \tree" is often called a branching in the optimization literature Pap], where the term \tree" is reserved for the undirected version. Throughout this paper we consistently use the term \tree" mean a directed rooted tree, possibly disconnected; however, for consistency with the literature, we refer to the algorithm we employ as \maximum branching algorithm."
A labeled tree T = (V; E; r; ) is a rooted tree with a positive real number (e) > 0 on each edge e 2 E. Labeled trees are useful as generators of distributions on 2 V . Suppose that we are given a labeled rooted tree T = (V; E; r; ), where for all e 2 E 0 < (e) 1. We call such a tree an oncogenetic tree; intuitively, we can think of (e) as the probability that edge e is present, with the events \edge e is present" being independent. We can then carry out the following experiment: Create a subtree of T by including each edge e with probability (e), independently; then consider the set S V of all vertices reachable from r. S is the outcome of the experiment. Thus, such an oncogenetic tree T generates a distribution P T on 2 V , where for each S V we have if r 2 S and there is a subset E 0 E such that S is the set of all vertices reachable from r in the tree (V; E 0 ; r), then
(1 ? ((u; v) );
In signi cant parts of the paper, we will use the logarithm of a probability, rather than the probability itself as an edge weight.
Oncogenetic trees are a simple but rigorous model of oncogenesis. It is assumed that the causality between genetic events is tree-like, and that a genetic event causation of a genetic event by another is independent of other such causations. Both assumptions are questionable, and are made for modeling simplicity and economy. A further objection, namely that such models do not capture the false positives and negatives due to experimental inaccuracies in CGH is discussed in the next section. Even if the true causality of oncogenesis is a much richer non-tree directed acyclic graph (that is, even if there is con uence of causality), it is hoped that most of the causality ows may be low enough in probability, and thus there is a tree-like model that captures accurately enough the dominant factors in oncogenesis. Similarly, statistical dependence of genetic events may be approximated adequately by independent edges. In any event, trees are a far richer model than the path models used so far in this arena Vog].
The simple oncogenetic tree model we have introduced fails to take into account time, a factor of obvious importance to oncogenesis. We next introduce a more elaborate model, which we call timed oncogenetic trees. A timed oncogenetic tree is a labeled tree T = (V; E; r; ), together with a distribution on the positive reals. Timed oncogenetic trees represent the following sampling process. First, for each edge e we draw a random variable t(e), exponentially distributed with mean 1 (e) . Second, we draw a real number t tot from distribution . We include a vertex v in the outcome of the sampling if and only if there is a path P from r to v in T, and the sum of all t(e)'s over all edges e on this path is at most t tot .
Thus, in a timed oncogenetic tree we assume that event r happens at time 0 (in the application of this model, event r will be an extraneous event signaling the beginning of the process). Once event u has happened, for each edge (u; v) 2 E event v is a Poisson event with rate . We select those events that have happened by time t tot , where t tot is drawn from a distribution which ideally re ects the time, relative to the oncogenetic process, at which a tumor is sampled from a patient.
Discussion of the Models
The timed oncogenetic tree model is a more realistic model of oncogenesis than the timeless oncogenetic tree, in which non-intersecting branches of the tree are independent. However, the timeless model also merits study because (a) it is more tractable mathematically, and (b) it is reasonable to hope that, once the best timeless oncogenetic tree has been identi ed, its structure will contain important clues about the best timed oncogenetic tree. In fact, we can show that in the case of paths the two models are equivalent:
Theorem 2.1 Let T = (V; E; r; ) be a timed oncogenetic tree of path topology with distribution . Then there is a timeless oncogenetic tree T 0 generating the same distribution.
Proof: Let T = (V; E; r; ) be a timed oncogenetic tree with edges (r; v 1 ); (v 1 ; v 2 ); : : : (v n?1 ; v n ):
We sample rst by choosing t tot according to . Let t i be the random variable that represents the time at which v i occurs. For v i 2 V , de ne i to be the distribution of t tot ? t i , conditioned upon t i < t tot . Let X be the set of events that occur before t tot .
Suppose e 1 = (r; v 1 ) has weight 1 : Conditioned on t tot = s; the probability of v 1 2 This result implies that our methods for reconstructing timeless oncogenetic trees in the next section will yield the correct timed oncogenetic tree when the underlying timed oncogenetic tree is of a path topology.
Our oncogenetic tree models borrow from the theory of ascending Markov chains and percolation processes (see e.g., Fil, Ric] ), known to be valuable as models of physical and biological systems. The timeless oncogenetic tree model is partly inspired by the closely related Cavender-Farris model for evolution Cav, Far, Ney] . A Cavender-Farris tree is also a rooted 7 tree T = (V; E; r; p) which is also used to generate a distribution on 2 V : First, r is in S. Then, for each edge e = (v i ; v j ), v j di ers from v i with respect to inclusion in S probability p e : If T is of star topology, then the oncogenetic tree model and the Cavender-Farris tree model are equivalent.
Finally, some notation. All our tree models de ne distributions on 2 V . We shall denote the distribution induced by oncogenetic tree T (timeless or timed, the context will be clear) as P T .
Let P be such a distribution. We shall need to de ne various associated probabilities. For v i ; v j 2 V; de ne
In this section we address the following important question: Given a set of CGH data, how can we nd the oncogenetic tree, in either model, that best ts the data? In its purest form, the problem is one of characterizing the class of distributions P T , for T an oncogenetic tree. This is not di cult in the case T is either a path (the support of P T immediately suggests T) or a star (the events should be independent), but very challenging in its generality. In practice it is further complicated by the fact that CGH data are known to contain false positives and negatives, corresponding to either experimental or observational errors, or genetic events irrelevant to the cancer under study. False negatives can be incorporated in our oncogenetic tree model by introducing, for each vertex v, a new vertex v 0 with intuitive meaning \genetic event v was observed," and an edge (v; v 0 ) with probability one minus that of the false negative. We see no simple way to incorporate false positives in our models.
In this section we develop a methodology for reconstructing oncogenetic trees from CGH data. We formally show that, in the absence of experimental errors, and unless the underlying tree has a certain anomaly analogous to the long branch attraction of Cavender-Farris trees, with enough data our method will correctly reconstruct the oncogenetic tree. Our result leads to explicit estimates on the size of data sets that are needed for the reconstruction method to be reliable.
It is an open problem, discussed in the last section, how our method fares in theory in the face of experimental errors and false negatives and positives. However, in the next section we apply it to CGH data for renal cancer, with results that appear to be very satisfactory.
Reconstruction by Maximum Branchings
Our approach to the reconstruction problem is the following: Based on the CGH data we construct a weight between the genetic events, that is, we assign a real w ij for each pair (i; j) of 8 genetic events; w ij is in general asymmetric. We then nd the rooted tree whose total weight (the sum of the weights of all edges in the tree) is maximized. The key algorithmic ingredient for this is a classical result due to Edmonds (see Edm, Kar, Tar, Pap] ) stating that the best rooted, directed tree can be found e ciently |in fact, in O(n 2 ) time, where n is the number of genetic events. Notice that this is not the better-known minimum spanning tree problem, which relates to undirected graphs, see Pap] . In the application of this method to real data, there is a preprocessing step in which we use a maximum clique heuristic to omit from further consideration certain genetic events whose occurrence in the CGH data appears not to be important.
Skewed Trees
We need to state and justify some assumptions about the probabilities of (combinations) of events to cope with real data and to prove that our reconstruction algorithm works. First, we need an assumption about edge probabilities to ensure that events are distinguishable and recognizable. Suppose e = (v i ; v j ) is an edge in an oncogenetic tree. Were we to allow (e) to approach 1 we the two events i and j might be indistinguishable. If (e) ! 0, it may impossible to observe i and j together in any sample of reasonable size. Furthermore, if v i is a vertex unlikely to be in a sample set, then its low probability must be allowed for. Also, if there is another edge (v i ; v k ), we must observe a reasonable number of sample sets where v j was included while v k was excluded, and vice versa.
Rigorously, we exclude all the above di culties by choosing a constant > 0 such that p i > for each event i, and that for each pair of events i; j either jp i ? p j j > , or p i ? p ij > : The parameter is critical later when we estimate the sample size needed to infer the correct tree with high probability.
If we could sample an oncogenetic tree in a noise-free environment, then reconstruction could be done as follows. We could de ne the \ancestor" partial order < T by v i < T v j i p ijj = 1: We then construct a tree T which agrees with the partial order. With perfect sampling, this simple algorithm will return T when enough samples have been taken to distinguish each edge of T. In practice, however, this algorithm will almost certainly return a star because: (1) even when the model is correct, the CNAs will not always occur in the order of the model Vog], (2) some of the CNAs that occur are truly random, and (3) the CGH experiment sometimes makes errors in reporting the CNAs. In the real data sets we have examined it is rare to nd two events A and B such that both occur in many tumors and the occurrence of A strictly implies the occurrence of B.
When noise is allowed in the sampling process, edge probabilities must be large enough to distinguish the in uence of edges from the in uence of noise. Consider the two timed oncogenetic trees T and T 0 of Figure 2 . We can choose the parameters, and the time distribution , so that the two distributions P T and P T 0 are extremely close. For example, let > 0 be chosen as a very small number. Suppose we use a two-state time distribution on the value of t, such that t = t 1 or t 2 each with probability 1=2: We may choose edge weights for T, 1 ; 2 such that P v 2 2 Xjt = t 1 ] = P v 1 2 Xjt = t 2 ] = 1=2; while P v 2 2 Xjt = t 2 ] 1 ? ; while P v 1 2 Xjt = t 1 ] :
Compare this distribution P T with the distribution P T 0 generated by taking p 3 = p 4 = 1=2. (In de ning P T the two trees are virtually indistinguishable. Hence, no algorithm will successfully distinguish between the two trees with less than astronomically large data.
The di culty with reconstructing T lies in the fact that the distribution does not adequately support the edge (r; v 2 ) instead of the edge (v 1 ; v 2 ): By allowing the fullest range of edge weights, we open the door to topological deception. This leads us to the following de nition of extreme pathological cases of oncogenetic trees:
De nition: Let T be an oncogenetic tree, generating distribution P T on V . We say T is skewed if there exists three distinct vertices v i ; v j ; v k 2 V; such that v k is the least common ancestor of v i ; v j , yet p ijj p i jjk .
Thus we say T is skewed if the edge (v i ; v j ) has greater support than the two edges (v k ; v i ) and (v k ; v j ). In a timeless oncogenetic tree p ijj = p ijk < p i jjk , so timeless oncogenetic trees are never skewed.
The Weight Functional
Our next step is to de ne a weight functional, that is, a mapping from probability distributions over 2 V to real weights for the pairs in V 2 . We shall use these weights to reconstruct the oncogenetic tree as the optimum branching (maximum-weight rooted tree) for these weights.
Intuitively, the weight w ij should re ect the desirability of having j as a direct descendant of i in the tree. First, it should re ect the likelihood ratio for i and j occurring together, that is, p ij p i p j . There should also be an asymmetry in the weight as well to re ect which CNA is likely to occur rst. If p i > p j , this means that event i occurs more often that event j; hence, it is more advantageous to have an edge from i to j than vice-versa. This suggests the following functional: w ij = p i p i + p j p ij p i p j
To be able to prove that the the reconstruction algorithm works, it turns out that the right choice is the logarithm of the above quantity:
w ij = log(p ij ) ? log(p i + p j ) ? log(p j )
(1):
If we were instead solving the minimum spanning tree problem, taking the logarithm or any other monotone increasing function, of the distances would not change the optimum tree. However, in the more elaborate case of branching, taking the logarithm may, in rare cases, change the optimum solution.
For weight functional (1) we can prove the following result:
Theorem 3.1 Let T be a non-skewed oncogenetic tree (timeless or timed). Then the maximum branching over V with respect to the weights de ned by equation (1) from the distribution P T is precisely T.
Since timeless oncogenetic trees are not skewed, and also since each timed oncogenetic path has an equivalent timeless oncogenetic path (by Theorem 2.1), Theorem 3.1 leads immediately to the following:
Corollary 3.2 Let T be a timeless or path-like, timed oncogenetic tree. The maximum branching over V with respect to the weights de ned by equation (1) from the distribution P T correctly reconstructs T.
To prove the theorem, let T be a non-skewed oncogenetic tree with root r, and let B be the maximum branching for the weights de ned by equation (1) from the distribution P T . We use three lemmas to show that B = T.
Lemma 3.3 The root of B is r.
For analyzing real data, r is an arti cially added vertex, conceptually representing the cell at time 0 with no CNAs. As such, there is no reason to keep the branching algorithm from arti cially making r to be the root. However, this complicates the algorithm, and since the simpler algorithm returns r as a root, this lemma is useful. is also its parent in B. Thus B = T. Theorem 3.1 appies when we know the precise probability distribution P T . In practice, however, we know P T through samples. It turns out that a slight modi cation of the proof of the theorem covers this case as well: Given a set of samples from P T , calculatep i ; andp ij , the observed values of p i and p ij for v i ; v j 2 V: and from theseŵ(v i ; v j ) = log(p ij )?log(p j )?log(p i +p j ); the observed value for w(v i ; v j ). Find the maximum branching B with respect toŵ. Theorem 3.6 If T is a non-skewed oncogenetic tree, then with su ciently many samples, the above algorithm will correctly construct the tree T with high probability.
To verify B = T, we use the three lemmas above. We rst analyze Lemmas 3.3 and 3.5 because they carry over to the probabilistic setting easily. Lemma 3.4 is where the non-skewness assumption is used in the proof. Therefore a more complicated estimation is needed to relate the number of samples needed for the Lemma to apply to a measure of how strongly the non-skewness assumption holds.
We rst test that r is the root of B. By equation (1) We now show that we may extend a version of Lemma 3.4 to the algorithm analysis. For v j 6 = r, we verify that if (v i ; v j ) 2 B, then v i is an ancestor of v j . Suppose not.
Let v j be the vertex closest to r which has been assigned a non-ancestor in T to be its parent inB. Let v i be its parent inB and let v k be the least common ancestor of v i ; v j in T. De ne ijj = p i_jjk ? p ijj . Since T is not skew, ijj > 0: LetB 0 be the branching obtained by deleting edge (v i ; v j ) and adding edge (v k ; v j ).
Suppose the branching contains edges (v i ; v j ) where v i is not an ancestor of v j . Let v j be the vertex closest to r which has been assigned a non-ancestor in T to be its parent inB. Let v i be its parent inB and let v k be the least common ancestor of v i ; v j in T. LetB 0 be the branching obtained by deleting edge (v i ; v j ) and adding edge (v k ; v j ). Then, referring back to equation ( 2) This proves a quantitative version of Theorem 3.6.
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Theorem 3.7 If T is a tree with n vertices (not including the root r), and p min is the minimum probability of observing any event, and is de ned as above, then with N = 8 ln n 2 p min samples of P T , the probability that the algorithm returns a false edge is less than 1=n 2 :
A realistic size for a tree might be 5 vertices, not including the arti cial root r; this is one more vertex than in the colorectal cancer path model. Based on the data sets we have seen p min = :2 is plausible if one uses only the most common events to build the tree. It is not possible to directly estimate the most important parameter . If = :1 it would take a number of samples near 6400 to get every tree edge correct with probability > 24=25. The error rate of 1=25 is appropriate as it loosely corresponds to a p-value of 0:04 in a eld where 0:05 is often used as a cuto . However, the sample size 6400 is nearly 2 orders of magnitude too large to reasonably expect from CGH studies using current technology. Nevertheless, one would hope that the tree inferred from a smaller sample still has a high probability having most edges correct.
The Size Statistic
In this subsection we de ne a statistic that is quite useful for establishing the relative temporal order of genetic events in oncogenesis. As we shall see, in the case of path trees, this simple statistic is su cient for reconstruction.
Let T = (V; E; r; ) be an oncogenetic tree (timeless or timed) with root r and vertex set V . Let s be a positive, real-valued function on V (T ) for a rooted tree T. We say s preserves the order of T if v i < T v j implies that s(v i ) s(v j ):
For v 2 V , de ne the size of v to be s(x) = E P T jXjjv 2 X], i.e., the expected number of CNAs in tumors that contain v. Intuitively, the later v occurs the more likely that it will occur together with more CNAs. Studies of the role of the Von-Hippel-Lindau gene in renal cancer suggest that it should be a ected early in the oncogenesis process and that a loss of this gene alone may not be su cient to cause renal cancer. One example of such a study is that of Thrash-Bingham et al. Thr] who used a di erent laboratory technique to look for only losses in 33 renal cell carcinomas, of which 13 cases are clear cell renal carcinomas like the 117 we considered. Among those 13 cases Thrash-Bingham et al. observed 5 losses on 3p, 4 losses on 14q, 3 losses on 8p, 2 losses on 6q and no other repeated losses. In their overall study they concluded that loss of 3p was associated with certain speci c other losses, but this does not follow for the 13 clear cell cases alone.
Before applying the branching algorithm it is necessary to select a small set of events to work with that appear to be most relevant. A model involving all 82 CNA events is clearly not appropriate. Because cancer inherently involves genetic instability and because CGH does have some false positives, many of the possible 82 events will show up in a small percentage of the tumors. To select events that seem most relevant we used a clique heuristic on the weighted graph of all 82 events. A clique is a subgraph in which all pairs of vertices are connected. For the clique computation the weight of an undirected edge is the sum of the two directed-edge weights de ned for the branching computation. We restricted attention to pairs of events that occurred at least 5 times together in the same tumor. We then found a maximum-weight clique of size 7. The choice of size 7 was due to time concerns with the clique selection routine. It is important to select enough events to get an interesting model, while small enough to include events that occur often enough to be very likely to be relevant to renal cancer. Our clique of size 7 includes: -4q, -13q, -3p, +17p, + 17q, -6q, -9p. We then applied the maximum-weight branching algorithm to the directed graph of these 7 vertices and the special vertex r. The edge structure of the best tree is shown in Figure 3 .
Our model is consistent with the established theory that a loss on 3p is an early important event for clear cell renal carcinoma, and suggests that it is not causatively associated with speci c other gains or losses. It is encouraging to see that changes in on 1q and 7q associated with papillary renal carcinomas do not show up in our model. It is also encouraging to see that a loss on 6q, which was one of the three other multiply-occurring events in Thr] does get selected in our much larger data set. Our model suggests that a loss on 4q is an important early event for clear cell renal carcinomas; a loss on 4q was observed in one case in Thr]. This is also weakly supported by a summary of 3 CGH studies on renal cancer in For] that showed a disproportionate number of cases with a loss on 4q, but this summary mixes together di erent types of renal cancer.
Discussion and Further Work
Comparative genome hybridization (CGH) is a powerful tool to explore the genetic defects underlying cancer. Since many cancers have heterogeneous genetic causes, mathematical modeling should help elucidate which CGH-detected aberrations may be causative and/or early prognosticators of tumor progression. The cancer genetics community has been quite excited by the path model for colorectal cancer Fea] , although analysis of CGH data for colorectal cancer suggest that it may be oversimpli ed Rie]. Moreover, other types of cancer do not seem to have useful path models. We proposed two classes of tree models to relate CGH data to tumor progression. We described an algorithm to infer trees from CGH data and we proved that under one assumption about the tree structure, the algorithm infers the correct tree. We also estimated the sample size needed to get every edge in the tree correct with high probability. We partially validated our approach on a renal cancer data set. Not enough is known experimentally about tumor progression and CGH-detectable aberrations to validate our models completely. Along these lines it should reiterated that the usage of time in our models re ects the inherent \ascertainment bias" that only tumors, not healthy cells, are sampled, and we know little about how long the tumor has existed when it is sampled. One could instead imagine that the distribution of the sampling times may depend on the state of the cell, but such a model seems more appropriate for cell lines grown in a laboratory where repeated sampling at designated intervals is feasible. The software used in Section 4 is available by sending email to either r.desper@dfkz-heidelberg.de or scha er@helix.nih.gov.
Our models imply that tumors of the type in the sample progress by starting at the root (no events) and then possibly adding any event whose parent in the tree has already been reached. They also imply that when certain combinations of vertices are reached, the abnormal cell would be su ciently abnormal to be considered cancerous. The information we are most interested in, however, is which events are children of the root (indicative of early events) and which events are parent-child (possible causal relationship). It is extremely hard to gure out the cause and e ect relationships in the laboratory, so a plausible model should be quite helpful to cancer geneticists.
It is not the case that reaching a single leaf implies cancer, as illustrated by our renal cancer model where the important event 3p-is a leaf next to the root. Current studies suggest that 3p-alone is insu cient for a renal cell to be cancerous. Our model suggests that for the type of renal cancer sampled, none of the 6 other events in the model occurs consistently after 3p-, although some of the tumors with 3p-do have many other gains or losses. We cannot easily infer which reached vertex sets are (not) cancerous because CGH data sets typically do not contain samples of cells that are abnormal, but not yet cancerous. The path model for colorectal cancer was in part validated because the genetic events along the path were correlated with clearly visible, pre-cancerous abnormalities on the colon. An oncologist would have no easy way to sample precancerous, abnormal cells, except when the abnormality is visible. There are some other cancers, such as melanoma, that have this helpful feature, but many common cancers such as breast and prostate cancer do not.
Among the problems we left open are:
How can one incorporate false positives into a tree model?
Is it possible to make the clique heuristic rigorous or to nd some other rigorous method for nding the most important CNA events?
For what other plausible weight functions does the branching construction infer the correct tree with high probability?
Suppose the best branching of any topology has weight W, while the star has weight S < W and the best path has weight P < W. Can these di erences in weight be converted into a p ? value for the hypothesis that the best model is not a star/path?
What is the computational complexity of the tree reconstruction problem: Given a probability distribution P on 2 V , nd a tree T such that some distance measure between P and P(T) is minimized?
FIGURE CAPTIONS
Figure 1: Graph structures of some possible oncogenetic models. part (a) is a path; part (b) is a star; part (c) is a tree that is neither a path nor a star, part (d) shows a two-component forest, part (e) shows a directed acyclic graph that is not a tree. In this paper, we allow structures (a),(b),(c), but we disallow (e). In models such as (d) we consider only the component with vertex r. 
